Molecular Medicine
The Molecular Medicine Residency Pathway within the Categorical Medicine Residency is designed for individuals who are interested in pursuing a career that emphasizes bench research in combination with the practice of medicine. The overarching goal of the program is to train the next generation of transformative laboratory-based physician-scientists.
The Molecular Medicine Residency Pathway provides specialized, individualized attention to each participant’s development as a bench scientist while maintaining the same broad and intensive exposure to clinical medicine that is enjoyed by all UCSF categorical internal medicine residents. Admission to the program is accompanied by a guaranteed subspecialty fellowship position within the Department of Medicine, contingent upon satisfactory completion of residency training. Successful applicants demonstrate potential for excellence in both clinical care and laboratory research, and will have completed a successful MD/PhD program or an in-depth research experience of at least one year.
Curriculum
Molecular Medicine Residents receive personal mentoring in selecting their area of research and choosing potential laboratories that may be of interest to them for postdoctoral training during their subspecialty fellowship. They also meet regularly as a group during the R2 (and R3 year, if applicable) for career development seminars, journal club presentations, and faculty research program presentations. Molecular Medicine Residents present cases that highlight pathophysiology to other UCSF residents in addition to UCSF MSTP students, and have an opportunity to participate in longitudinal mentorship with students and fellows. There are occasional social events with the broader Molecular Medicine community. Dedicated time for scholarly activity is provided during the R2 year (and R3 year, if applicable). During the R2 year, Molecular Medicine Residents attend an annual off-site 3-day research retreat of the Biomedical Sciences Program, where they can learn more about the rich scientific opportunities at UCSF and an have opportunity to fully immerse themselves in basic/translational science. Historically, the majority of Molecular Medicine Residents have opted to short-track into the ABIM Research Pathway, pending approval from the Categorical Residency Program Director.
Current Molecular Medicine Residents
*Learn more about current and former Molecular Medicine residents at UCSF.
Year |
Name and Degree(s) |
Degree Granting Institution |
---|---|---|
2022 | Jawara Allen, MD, PhD |
Johns Hopkins University |
2022 | Miranda Culley, MD, PhD |
University of Pittsburgh |
2022 | Bohao Liu, MD, PhD |
Columbia University |
2022 | Daniel Lyons, MD, PhD |
University of Michigan |
2022 | Trisha Macrae, MD, PhD |
University of California, San Francisco |
2022 | Suhas Rao, MD, PhD |
Stanford University |
2021 |
Nia Adeniji, MD |
Stanford University |
2021 |
Erik Bao, MD |
Harvard University |
2021 |
Sherry Chao, MD, PhD |
University of North Carolina, Chapel Hill |
2021 |
Adolfo Cuesta, MD, PhD |
University of California, San Francisco |
2021 |
John Lazar, MD, PhD |
University of Washington |
2021 |
Ramya Parameswaran, MD, PhD |
University of Chicago |
2021 |
Gloria Tavera, MD, PhD |
Case Western Reserve University |
2021 |
Julia Wagner, MD, PhD |
Washington University in St. Louis |
2021 |
Allison Wong, MD PhD |
University of California, San Francisco |
2021 | Constance Wu, MD |
Harvard University |
2020 |
Benjamin Hoffman, MD, PhD |
Columbia University |
2020 |
Alissa Kleinhenz, MD |
University of Michigan |
2020 |
Coyin Oh, MD |
Harvard University |
Recent Participants
Degree Granting Institution | Name | Subspecialty |
---|---|---|
2020 University of Washington | Erin dela Cruz, MD, PhD | Infectious Diseases, UCSF |
2020 Washington University, St. Louis |
Vivek Durai, MD, PhD | Cardiology, UCSF |
2020 University of Utah |
Nathan Krah, MD, PhD | Hematology/Oncology, University of Utah |
2020 Harvard University | Donna Leet, MD | Gastroenterology, UCSF |
2020 UCSF |
Sophia Levan, MD, PhD | Pulmonary and Critical Care, UCSF |
2020 Cornell University |
Alejandro Lopez, MD, PhD | Gastroenterology, UCSF |
2020 University of Chicago | Rangarajan Nadadur, MD, PhD | Cardiology, UCSF |
2020 Cornell University |
Kimberly Rickman, MD PhD | Hematology and Oncology, UCSF |
2019 UCSF |
Ryan Chang, MD, PhD | Hematology and Oncology, UCSF |
2019 Harvard University |
Mai Dao, MD | Gastroenterology, UCSF |
2019 Faculte de Medecine Paris Descartes |
Charlotte Hurabielle-Claverie, MD, PhD |
Rheumatology, UCSF |
2019 Boston University |
Anjali Jacob, MD, PhD |
Pulmonary and Critical Care, UCSF |
2019 University of Chicago |
Matthew Jones, MD, PhD |
Hematology and Oncology, UCSF |
2019 Harvard University |
Vipul Kumar, MD, PhD |
Hematology and Oncology, UCSF |
2019 UCSF |
Andrew Lechner, MD, PhD | Pulmonary and Critical Care, UCSF |
2019 Harvard University |
Quinlan Sievers, MD, PhD | Hematology and Oncology, UCSF |
2019 Harvard University |
Jeremiah Wala, MD, PhD |
Hematology and Oncology, DFCI |
2019 UCSF |
Robert Weber, MD, PhD | Endocrinology, UCSF |
2018 UCSF |
Christina Homer, MD, PhD |
Infectious Diseases, UCSF |
2018 University of Pennsylvania |
Sarah Hsu, MD, PhD |
Hematology and Oncology, UCSF |
2018 Duke University |
Jerry Lee, MD |
Hematology and Oncology, UCSF |
2018 UCSF |
T. Richard Parenteau, MD, PhD |
Geriatrics, UCSF |
2018 University of Iowa |
Joshua Schoenfeld, MD, PhD |
Hematology and Oncology, Memorial Sloan-Kettering Cancer Center |
2018 Harvard University |
Travis Zack, MD, PhD |
Hematology and Oncology, UCSF |
2018 UCSF |
John Huizar, MD |
Rheumatology, UCSF |
2018 Johns Hopkins University |
Worawan Limpitikul, MD, PhD |
Cardiology, MGH |
2018 Columbia University |
Natasha Spottiswoode, MD, PhD |
Infectious Diseases, UCSF |
2017 New York University |
Adam Blaisdell, MD, PhD |
Gastroenterology, UCSF |
2017 Univeristy of Pittsburgh |
John Demko, MD |
Nephrology, UCSF |
2017 University of California, Irvine |
Kelly Fitzgerald, MD |
Hematology and Oncology, Memorial Sloan-Kettering Cancer Center |
2017 Yale |
Brendan Huang, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCLA |
2017 University of North Carolina |
Meghan Jobson, MD, PhD |
Palliative Care, UCSF |
2017 Cornell |
Corynn Kasap, MD, PhD |
Hematology and Oncology, UCSF |
2017 Cornell |
Maxime Kinet, MD, PhD |
Rheumatology, UCSF |
2017 Icahn School of Medicine at Mt Sinai |
Noa Simchoni, MD, PhD |
Hospital Medicine, UCSF |
2017 UCSF |
Noah Younger, MD, PhD |
Hematology and Oncology, UCSF |
2016 Yale |
Nancy Allen, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2016 Columbia |
Stewart Cao, MD, PhD |
Gastroenterology, Washington University, St. Louis |
2016 University of Michigan |
Cailin Collins, MD, PhD |
Hematology and Oncology, Stanford University |
2016 Baylor |
Andrew Folick, MD, PhD |
Endocrinology, UCSF |
2016 Icahn School of Medicine at Mount Sinai |
Arielle Klepper, MD, PhD |
Gastroenterology, UCSF |
2016 Pennsylvania State University College of Medicine |
Michelle Matzko, MD, PhD |
Infectious Diseases, MGH/BWH |
2016 UCSF |
Alex Mohapatra, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2016 Baylor |
Kapil Saxena, MD |
Hematology and Oncology, MDACC |
2015 University of Pennsylvania |
Chukwuka Didigu, MD, PhD |
Hematology and Oncology, UCSF |
2015 Harvard |
Laura Huppert, MD, |
Hematology and Oncology, UCSF |
2015 Washington University |
Hailyn Nielsen, MD, PhD |
Rheumatology, UCSF |
2015 University of Chicago |
Vaibhav Upadhyay, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2014 Harvard |
Vincent Auyeung, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2014 UCSF |
Alan Baik, MD |
Cardiology, UCSF |
2014 UCSF |
Jonathan Chou, MD, PhD |
Hematology and Oncology, UCSF |
2014 University of Washington |
Joseph Hiatt, MD, PhD |
Hematology and Oncology, University of Washington |
Application Logistics
Upon receipt of the electronic Residency Application from ERAS, the Residency Admissions Committee selects applicants for interview at UCSF. Applicants invited for an interview are then asked if they wish to be considered for the Molecular Medicine Residency. A separate selection committee reviews applicants and issues invitations to remain an extra day after the Categorical Residency application day to interview specifically for the Molecular Medicine Residency.
As stated above, acceptance into the Molecular Medicine Residency includes a commitment of a fellowship position in a specialty of choice. A Molecular Medicine Residency participant, however, may also choose not to specify a particular specialty and, instead, wait to apply after exploring different opportunities during residency.
The UCSF Molecular Medicine Residency Program is fully committed to enhancing diversity at UCSF.
Applications from women and under-represented ethnic/cultural groups are strongly encouraged.
Neil P. Shah, MD PhD
Director, UCSF Molecular Medicine Residency Program
Aparna Sundaram, MD
Associate Director, UCSF Molecular Medicine Residency Program
Contact Us
Additional questions may be addressed to Eva Gamboa.
Eva Gamboa
[email protected]
Thank you for your interest in the UCSF Molecular Medicine Residency Program.